Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Johnson & Johnson, Memphasys, Procter & Gamble - for a better life

Good health is a valuable possession. Small and large companies around the globe are engaged in research and development to make people's lives easier or better through modern and innovative products and solutions. The consumer goods and pharmaceutical sectors often offer attr...
Mario Hose | April 16, 2020 |

Kyorin's $175M Partnership Offers Good Life for aTyr Pharma in Japan

aTyr Pharma's shares traded 45% higher today after the firm reported that it had entered into a collaboration agreement with Kyorin Pharmaceutical for development and commercialization of its ATYR1923 drug in Japan. This morning, biotherapeutics company aTyr Pharma I...
Streetwise Reports | January 7, 2020 |

Reata Pharma Announces $350 Million Strategic Investment from Blackstone Life Sciences

Shares of Reata Pharmaceuticals traded 30% higher after reporting that Blackstone Life Sciences will invest $350 million in the company to advance bardoxolone methyl as a potential therapy for Alport syndrome and other rare and serious chronic kidney diseases. Clin...
Streetwise Reports | June 12, 2020 |

Riverside Resources – Strategic, Accretive, and Blue Sky

Riverside Resources (TSX.V: RRI | OTCQB: RVSDF ) In this exclusive interview, Dr. John-Mark Staude of Riverside Resources sits down with Maurice Jackson of Proven and Probable to discuss the strategic acquisition the company has made to expand the property bank footp...
Maurice Jackson | September 25, 2019 |

Crossing the Rubicon into the Super Premium Cannabis Space

Rubicon Organics Inc. ( CSE: ROMJ , OTCQX: ROMJF , Forum ) is a licensed cannabis producer focused on cultivating and branding certified organic, super-premium cannabis. Rubicon trades on the Canadian Securities Exchange under the symbol ROMJ. In this fascina...
Dave Jackson | April 3, 2020 |

Cultivating. Innovating. Operating: Discovering the Science of CBD

Sire Bioscience Inc’s ( CSE.SIRE , OTC: BLLXF , Forum ) business model is based on their ability to engage in the investment, production, and sale of hemp for CBD extraction. That’s the desirable scalable endgame for any cannabis company....
Dave Jackson | May 13, 2020 |

Crude Cuts Get Another Saudi Boost as Oil Demand Begins to Show Signs of Life

Saudi Arabia enhanced their commitment to OPEC+ supply cuts as the Kingdom said they'd shut production of additional 1 million barrels of crude oil per day next month. Most of the OPEC+ countries have already come close to compliance with the deal that took effect this mo...
Streetwise Reports | May 22, 2020 |

Analyst Upgrade Ignites Duchenne's Muscular Dystrophy Research Firm's Shares

Solid Biosciences' shares are up by more than 40% today after Chardan Capital Markets upgraded the firm's shares from "neutral" to "buy" and raised its price target from $7.50 to $10.00/share. Duchenne muscular dystrophy (DMD) research firm Solid Biosciences ...
Streetwise Reports | August 20, 2019 |

Aurora Cannabis, EXMceuticals, Tilray - Cannabis development in Portugal

From the street to the clinic. Cannabis had the image of an illegal street drug in most rich countries since the prohibition in the USA in the 1930s. Although cannabis has been used as a medicinal plant for more than 1,000 years, the past decades have been marked by other phar...
Mario Hose | February 4, 2020 |

Aurora, Bayer, XPhyto - scalable growth markets with potential

Health is the most precious good in the life of a human being. The preservation and improvement of the quality of life is a large business area. Investors around the globe have the opportunity to participate in many different areas of research and development of products and t...
Mario Hose | June 8, 2020 |
1 2 3 4 5 6 7 8 9 10 ...